Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ciclum Farma is a prominent Portuguese pharmaceutical company that specializes in the commercialization of generic medicines and consumer healthcare products. Established in 1998 and based in Paço de Arcos, the company has been a subsidiary of the international STADA Group since 2001. Ciclum Farma maintains a diverse portfolio that addresses major therapeutic areas such as cardiovascular health, central nervous system disorders, and gastroenterology. The company is a key contributor to the Portuguese healthcare system by providing cost-effective alternatives to brand-name drugs, ensuring broader patient access to essential treatments. In addition to prescription generics, Ciclum Farma markets a variety of over-the-counter (OTC) brands and nutritional supplements. By leveraging the global manufacturing and R&D infrastructure of the STADA Group, Ciclum Farma continues to expand its presence in the Iberian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ciclum Farma.